Ritesh Rikain Warty

Ritesh Rikain Warty

Auto-generated profile, based on publicly available information

Ritesh Rikain Warty

Department of Obstetrics and Gynaecology, Monash University, Clayton, Victoria, Australia

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 November 2020 in Journal of Medical Internet Research
Verified
Journal Article
Open access
VSVinayak Smith
Vinayak Smith
RWRitesh Rikain Warty
Ritesh Rikain Warty
JSJoel Arun Sursas
Joel Arun Sursas
OPOlivia Payne
Olivia Payne
ANAmrish Nair
Amrish Nair
BVBeverley Vollenhoven
Beverley Vollenhoven
Background: Virtual reality is increasingly being utilized by clinicians to facilitate analgesia and anxiolysis within an inpatient setting. There is however, a lack of a clinically relevant review to guide its use for this purpose. Objective: To systematically review the current evidence for the efficacy of virtual reality as an analgesic in the management of acute pain and anxiolysis in an inpatient setting. Methods: A comprehensive search was conducted up to and including January 2019 on PubMed, Ovid Medline, EMBASE, and Cochrane Database of Systematic reviews according to PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) guidelines. Search terms included virtual reality, vr, and pain. Primary articles with a focus on acute pain in the clinical setting were considered for the review. Primary outcome measures included degree of analgesia afforded by virtual reality therapy, degree of anxiolysis afforded by virtual reality therapy, effect of virtual reality on physiological parameters, side effects precipitated by virtual reality, virtual reality content type, and type of equipment utilized. Results: Eighteen studies were deemed eligible for inclusion in this systematic review; 67% (12/18) of studies demonstrated significant reductions in pain with the utilization of virtual reality; 44% (8/18) of studies assessed the effects of virtual reality on procedural anxiety, with 50% (4/8) of these demonstrating significant reductions; 28% (5/18) of studies screened for side effects with incidence rates of 0.5% to 8%; 39% (7/18) of studies evaluated the effects of virtual reality on autonomic arousal as a biomarker of pain, with 29% (2/7) demonstrating significant changes; 100% (18/18) of studies utilized a head mounted display to deliver virtual reality therapy, with 50% being in active form (participants interacting with the environment) and 50% being in passive form (participants observing the content only). Conclusions: Available evidence suggests that virtual reality therapy can be applied to facilitate analgesia for acute pain in a variety of inpatient settings. Its effects, however, are likely to vary by patient population and indication. This highlights the need for individualized pilot testing of virtual reality therapy’s effects for each specific clinical use case rather than generalizing its use for the broad indication of facilitating analgesia. In addition, virtual reality therapy has the added potential of concurrently providing procedural anxiolysis, thereby improving patient experience and cooperation, while being associated with a low incidence of side effects (nausea, vomiting, eye strain, and dizziness). Furthermore, findings indicated a head mounted display should be utilized to deliver virtual reality therapy in a clinical setting with a slight preference for active over passive virtual reality for analgesia. There, however, appears to be insufficient evidence to substantiate the effect of virtual reality on autonomic arousal, and this should be considered at best to be for investigational uses, at present.

1 January 2023 in Human Reproduction Open
Verified
Journal Article
Open access
PDF file
MSM Salih
M Salih
CAC Austin
C Austin
RWR R Warty
R R Warty
CTC Tiktin
C Tiktin
DRDaniel Rolnik
Daniel Rolnik
FHF Horta
F Horta
What is the present performance of artificial intelligence (AI) decision support during embryo selection compared to the standard embryo selection by embryologists? AI consistently outperformed the clinical teams in all the studies focused on embryo morphology and clinical outcome prediction during embryo selection assessment. The ART success rate is ∼30%, with a worrying trend of increasing female age correlating with considerably worse results. As such, there have been ongoing efforts to address this low success rate through the development of new technologies. With the advent of AI, there is potential for machine learning to be applied in such a manner that areas limited by human subjectivity, such as embryo selection, can be enhanced through increased objectivity. Given the potential of AI to improve IVF success rates, it remains crucial to review the performance between AI and embryologists during embryo selection. The search was done across PubMed, EMBASE, Ovid Medline, and IEEE Xplore from 1 June 2005 up to and including 7 January 2022. Included articles were also restricted to those written in English. Search terms utilized across all databases for the study were: (‘Artificial intelligence’ OR ‘Machine Learning’ OR ‘Deep learning’ OR ‘Neural network’) AND (‘IVF’ OR ‘in vitro fertili*’ OR ‘assisted reproductive techn*’ OR ‘embryo’), where the character ‘*’ refers the search engine to include any auto completion of the search term. A literature search was conducted for literature relating to AI applications to IVF. Primary outcomes of interest were accuracy, sensitivity, and specificity of the embryo morphology grade assessments and the likelihood of clinical outcomes, such as clinical pregnancy after IVF treatments. Risk of bias was assessed using the Modified Down and Black Checklist. Twenty articles were included in this review. There was no specific embryo assessment day across the studies—Day 1 until Day 5/6 of embryo development was investigated. The types of input for training AI algorithms were images and time-lapse (10/20), clinical information (6/20), and both images and clinical information (4/20). Each AI model demonstrated promise when compared to an embryologist’s visual assessment. On average, the models predicted the likelihood of successful clinical pregnancy with greater accuracy than clinical embryologists, signifying greater reliability when compared to human prediction. The AI models performed at a median accuracy of 75.5% (range 59–94%) on predicting embryo morphology grade. The correct prediction (Ground Truth) was defined through the use of embryo images according to post embryologists’ assessment following local respective guidelines. Using blind test datasets, the embryologists’ accuracy prediction was 65.4% (range 47–75%) with the same ground truth provided by the original local respective assessment. Similarly, AI models had a median accuracy of 77.8% (range 68–90%) in predicting clinical pregnancy through the use of patient clinical treatment information compared to 64% (range 58–76%) when performed by embryologists. When both images/time-lapse and clinical information inputs were combined, the median accuracy by the AI models was higher at 81.5% (range 67–98%), while clinical embryologists had a median accuracy of 51% (range 43–59%). The findings of this review are based on studies that have not been prospectively evaluated in a clinical setting. Additionally, a fair comparison of all the studies were deemed unfeasible owing to the heterogeneity of the studies, development of the AI models, database employed and the study design and quality. AI provides considerable promise to the IVF field and embryo selection. However, there needs to be a shift in developers’ perception of the clinical outcome from successful implantation towards ongoing pregnancy or live birth. Additionally, existing models focus on locally generated databases and many lack external validation. This study was funded by Monash Data Future Institute. All authors have no conflicts of interest to declare. CRD42021256333

6 October 2021 in IEEE Access
Verified
Journal Article
Open access
RWRitesh Rikain Warty
Ritesh Rikain Warty
VSVinayak Smith
Vinayak Smith
MSMohamed Salih
Mohamed Salih
DPDeborah Fox, RM, B Mid, M Sc, PhD
Deborah Fox, RM, B Mid, M Sc, PhD
SMSally L. Mcarthur
Sally L. Mcarthur
BMBen Willem Mol
Ben Willem Mol
Implementing medical devices into a clinical setting is a complex and lengthy process. Existing models, such as Rogers’ Diffusion of Innovation, try to elucidate this process, however, need to be updated to the evolving healthcare context as fewer than 7% of devices achieve implementation. The aim of this systematic review was to describe the barriers to diffusion in relation to this model to understand why so few technologies are implemented and how to address these challenges to mitigate risk during the translation process. To do this, we searched PubMed, Medline, and Embase databases for studies published between 01/01/1999 – 30/10/2019. Theoretical and application studies were included, and thematic analysis was employed using the Braun and Clarke framework to generate broad themes from the specific concepts described by included studies. A total of 33 articles were eligible for inclusion. Innovation processes constituting an obstacle to diffusion included: technology-specific challenges (8/33), clinical evidence/uncertainty (5/33), regulatory affairs (6/33), health technology assessment (7/33), reimbursement (15/33), and adoption (6/33). The factors that contributed to these themes were identified as being associated to the 11 tenets of Rogers’ Diffusion of Innovation. This allowed the discussion of the identified barriers to medical device diffusion in relation with the Rogers’ model. This analysis enabled the development and proposal of a framework that incorporates considerations within commercialization and translation strategies for these barriers to ultimately facilitate medical technology implementation.

31 March 2023 in Health Care for Women International
Verified
Journal Article
Open access
RWRitesh Rikain Warty
Ritesh Rikain Warty
VSVinayak Smith
Vinayak Smith
MPMalitha Patabendige
Malitha Patabendige
DPDeborah Fox, RM, B Mid, M Sc, PhD
Deborah Fox, RM, B Mid, M Sc, PhD
BMBWJ Mol
BWJ Mol
Medical technologies are pervasive across women’s health, spanning across obstetric and gynecological care. FemTech, the sector responsible for developing these technologies, is growing at 15.6% per annum. However, there are concerns of disconnects between new product development (NPD) and the care afforded to women in consequence of implementing these innovations. The most crucial stage of NPD involves understanding the clinical need. Without a clear need and clinical use case, innovators risk developing solutions which do not address the issues women and caregivers experience. Thus, the product will miss the market and experience limited uptake. Tools for performing clinical needs assessments and defining the use case are being developed. This review provides an analysis of their strengths and weaknesses to inform FemTech innovators of the available resources. We further discuss concepts for creating a unified approach to assessing unmet needs such that technologies have a higher chance of improving women’s healthcare.

5 October 2024 in American Journal of Obstetrics & Gynecology MFM
Verified
Journal Article
Open access
DSDensearn Seo
Densearn Seo
RKRashvinder Kaur
Rashvinder Kaur
MPMeghna Prasannan Ponganam
Meghna Prasannan Ponganam
KSKah Wai Sam
Kah Wai Sam
MHMaclean Hill
Maclean Hill
KPKirsten R Palmer
Kirsten R Palmer
Induction of labor is commonly undertaken when ongoing pregnancy poses risk to either mother or fetus. Often cervical preparation is required with mechanical methods increasingly popular due to their improved safety. This study evaluates the efficacy, safety, and acceptability of digital versus speculum-based balloon insertion for cervical preparation, aiming to identify gaps and inform future research. PubMed, Ovid MEDLINE, EMBASE, and Scopus were searched from database inception until 30 June 2023. Included studies were randomized controlled trials comparing digital versus speculum-based insertion of catheter-related balloons for labor induction in individuals with viable singleton pregnancies, in both inpatient and outpatient settings, written in English. Exclusions included studies not using cervical balloons, comparisons to non-balloon methods, non-human studies, and non-primary literature like guidelines, reviews, commentaries, and opinion pieces. Title and abstract screening were performed by four authors. Full-text articles were assessed against inclusion criteria. Selection was agreed upon by consensus among three authors, with a fourth consulted for disputes. Risk of bias was assessed using the Cochrane Risk of Bias Tool 2.0 for randomized trials. A meta-analysis was also performed. Out of 3397 studies, four met the inclusion criteria, all being randomized controlled trials with some concerns in at least one domain but no high risk of bias. Two studies found digital insertion significantly less painful than speculum-based insertion (p<0.001), while one reported no difference (p=0.72). Maternal satisfaction was comparable, with one study favouring digital insertion (p=0.011). Meta-analysis findings for other outcome measures suggest no difference between speculum or digital insertion. However, due to substantial heterogeneity, findings for procedural time, time from induction-to-delivery, and epidural rate should be cautiously interpreted. Digital insertion for cervical preparation appears associated with reduced pain and higher patient acceptability compared to speculum-based insertion. Additionally, efficacy and safety were comparable, indicating it is a preferable option for clinical use. There was no difference in other procedural, obstetric, or neonatal outcomes, however, more rigorous research employing standardised outcome measures is needed to facilitate a clinically meaningful interpretation.

20 March 2025 in American Journal of Obstetrics and Gynecology
Verified
Journal Article
Closed access
DNDurga Naidu
Durga Naidu
RMRohan Modi
Rohan Modi
MKMugdha Kulkarni
Mugdha Kulkarni
VGVarman Gunasaegaram
Varman Gunasaegaram
DRDaniel L. Rolnik
Daniel L. Rolnik
RWRitesh Rikain Warty
Ritesh Rikain Warty